Home » UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE

UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE

July 3, 2006

Belgian pharmaceutical company UCB SA said Monday it may be interested in Eli Lilly & Co.'s (LLY) research and development center at Mont-Saint-Guibert in Belgium.
Easy Bourse

KEYWORDS FDAnews Drug Daily Bulletin

Upcoming Events

12Feb
Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline...
17Mar
FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers
19Mar
SOPs and Policies for the 21st Century: Why Less is More
20Apr
17th Annual Medical Device Quality Congress

New!

17th Medical Device Quality Congress

Learn More Here

UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE

Upcoming Events

Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline...

FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers

SOPs and Policies for the 21st Century: Why Less is More

17th Annual Medical Device Quality Congress

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

STRATA Gains 510(k) Clearance for XTRAC Momentum Laser Platform

FDA Adds Chemically Synthesized Products to NDA-BLA Transition List

VivaLNK Wearable ECG Sensor Platform Cleared

Advisory Committee Deadlocks on Durect’s Post-Surgical Analgesic

New!

17th Medical Device Quality Congress